Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease - PubMed (original) (raw)
. 2008 Jan;104(2):420-34.
doi: 10.1111/j.1471-4159.2007.04996.x. Epub 2007 Oct 22.
Affiliations
- PMID: 17953654
- DOI: 10.1111/j.1471-4159.2007.04996.x
Free article
Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease
Mritunjay Pandey et al. J Neurochem. 2008 Jan.
Free article
Abstract
Mitochondrial complex-I dysfunction has been observed in patients of Huntington's disease (HD). We assessed whether such a defect is present in the 3-nitropropionic acid (3-NP) model of HD. Rats treated with 3-NP (10-20 mg/kg i.p., for 4 days) exhibited weight loss, gait abnormalities, and striatal lesions with increased glial fibrillary acidic protein immunostaining on fifth and ninth days, while increase in striatal dopamine and loss of tyrosine hydroxylase immunoreactivity were observed on fifth day following treatment. We report for the first time a dose-dependent reduction in complex-I activity in the cerebral cortex when analyzed spectrophotometrically and by blue native-polyacrylamide gel electrophoresis following 3-NP treatment. The citrate synthase normalized activities of mitochondrial complex-I, -II, -(I + III) and -IV were decreased in the cortex of 3-NP treated rats. In addition, succinate driven State 3 respiration was also significantly inhibited in vivo and in the isolated mitochondria. These findings taken together with the observation of a significant decrease in vivo but not in vitro of State 3 respiration with NAD(+)-linked substrates, suggest complex-I dysfunction in addition to irreversible inhibition of complex-II and succinate dehydrogenase activity as a contributing factor in 3-NP-induced cortico-striatal lesion.
Similar articles
- Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P, Kumar A. Kumar P, et al. Behav Brain Res. 2010 Jan 5;206(1):38-46. doi: 10.1016/j.bbr.2009.08.028. Epub 2009 Aug 27. Behav Brain Res. 2010. PMID: 19716383 - Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R. Pandey M, et al. Neurochem Int. 2009 Nov;55(6):431-7. doi: 10.1016/j.neuint.2009.04.013. Epub 2009 May 4. Neurochem Int. 2009. PMID: 19410615 - Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A, Akula KK, Kulkarni SK. Dhir A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):835-43. doi: 10.1016/j.pnpbp.2007.12.017. Epub 2008 Jan 29. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18234412 - Neuroprotective mechanisms of brain-derived neurotrophic factor against 3-nitropropionic acid toxicity: therapeutic implications for Huntington's disease.
Wu CL, Hwang CS, Chen SD, Yin JH, Yang DI. Wu CL, et al. Ann N Y Acad Sci. 2010 Jul;1201:8-12. doi: 10.1111/j.1749-6632.2010.05628.x. Ann N Y Acad Sci. 2010. PMID: 20649532 Review. - Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
Browne SE. Browne SE. Ann N Y Acad Sci. 2008 Dec;1147:358-82. doi: 10.1196/annals.1427.018. Ann N Y Acad Sci. 2008. PMID: 19076457 Review.
Cited by
- Understanding the Multiple Role of Mitochondria in Parkinson's Disease and Related Disorders: Lesson From Genetics and Protein-Interaction Network.
Nicoletti V, Palermo G, Del Prete E, Mancuso M, Ceravolo R. Nicoletti V, et al. Front Cell Dev Biol. 2021 Apr 1;9:636506. doi: 10.3389/fcell.2021.636506. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33869180 Free PMC article. Review. - Inhibition of EPAC2 Attenuates Intracerebral Hemorrhage-Induced Secondary Brain Injury via the p38/BIM/Caspase-3 Pathway.
Zhuang Y, Xu H, Richard SA, Cao J, Li H, Shen H, Yu Z, Zhang J, Wang Z, Li X, Chen G. Zhuang Y, et al. J Mol Neurosci. 2019 Mar;67(3):353-363. doi: 10.1007/s12031-018-1215-y. Epub 2019 Jan 3. J Mol Neurosci. 2019. PMID: 30607901 - Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X, Manczak M, Reddy PH. Yin X, et al. Hum Mol Genet. 2016 May 1;25(9):1739-53. doi: 10.1093/hmg/ddw045. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908605 Free PMC article. - Attention deficit-hyperactivity disorder suffers from mitochondrial dysfunction.
Verma P, Singh A, Nthenge-Ngumbau DN, Rajamma U, Sinha S, Mukhopadhyay K, Mohanakumar KP. Verma P, et al. BBA Clin. 2016 Oct 18;6:153-158. doi: 10.1016/j.bbacli.2016.10.003. eCollection 2016 Dec. BBA Clin. 2016. PMID: 27896136 Free PMC article. - Neurological sequel of chronic kidney disease: From diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain.
Mazumder MK, Paul R, Bhattacharya P, Borah A. Mazumder MK, et al. Sci Rep. 2019 Feb 28;9(1):3097. doi: 10.1038/s41598-018-37935-3. Sci Rep. 2019. PMID: 30816118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous